Factors affecting risk of symptomatic temporal lobe necrosis: Significance of fractional dose and treatment time

International Journal of Radiation Oncology Biology Physics

Volumn 53, Issue 1, 2002, Pages 75-85

  Lee, Anne W M ^a   Kwong, Dora L W ^b   Leung, Sing Fai ^c   Tung, Stewart Y ^d   Sze, Wai Man ^a   Sham, Jonathan S T ^b   Teo, Peter M L ^c   Leung, To Wai ^d   Wu, Po Man ^b   Chappell, Rick ^e   Peters, Lester J ^f   Fowler, John F ^g  

^a PAMELA YOUDE NETHERSOLE EASTERN HOSPITAL   (Hong Kong)

^b QUEEN MARY HOSPITAL   (Hong Kong)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d TUEN MUN HOSPITAL   (Hong Kong)

^e University of Wisconsin Madison   (United States)

^f PETER MACCALLUM CANCER CENTRE   (Australia)

^g UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Brain necrosis; Dose; Fractionation; Nasopharyngeal carcinoma; Time

Indexed keywords

TREATMENT TIME;

BIOMEDICAL ENGINEERING; CHEMOTHERAPY; DOSIMETRY; IRRADIATION; MULTIVARIABLE SYSTEMS;

RADIOTHERAPY;

CISPLATIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BRACHYTHERAPY; BRAIN NECROSIS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RISK FACTOR; TEMPORAL LOBE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARCINOMA; DOSE FRACTIONATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RISK; TEMPORAL LOBE;

EID: 0036570252     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)02711-6     Document Type: Article

References (61)

1. Lokales amyloid in Gehirn
2. Cerebral radiation necrosis following treatment of extracranial malignancies
3. Cerebral necrosis following radiotherapy of extracranial neoplasms
4. Nasopharynx
5. Retrospective analysis of nasopharyngeal carcinoma treated during 1976-1985: Late complications following megavoltage irradiation
6. Effect of time, dose and fractionation on temporal lobe necrosis following radiotherapy for nasopharyngeal carcinoma
7. Asymptomatic temporal lobe injury after radiotherapy for nasopharyngeal carcinoma: Incidence and determinants
8. Early tumor response and treatment toxicity after hyperfractionated radiotherapy in nasopharyngeal carcinoma
9. Final report of a randomized trial on altered-fractionated radiotherapy in nasopharyngeal carcinoma prematurely terminated by significant increase in neurological complications
10. Carcinoma of the nasopharynx
11. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003
12. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: Results of the EORTC 22851 randomized trial
13. The DAHANCA 6 and 7 trial: A randomized multicenter study of 5 versus 6 fractions per week of conventional radiotherapy of squamous cell carcinoma (SCC) of the head and neck
14. Randomized clinical trial on 7-day-continuous accelerated irradiation (CAIR) of head and neck cancer - Report on 3-year tumor control and normal tissue toxicity
15. Stage classification of nasopharyngeal carcinoma: A review
16. Dose fractionation, dose rate and iso-effect relationships for normal tissue responses
17. The linear quadratic formula and progress in fractionated radiotherapy
18. Clinical diagnosis of late temporal lobe necrosis following radiation therapy for nasopharyngeal carcinoma
19. Magnetic resonance imaging in the clinical diagnosis of late temporal lobe necrosis following radiotherapy for nasopharyngeal carcinoma
20. Nonparametric estimation from incomplete observations
21. Design and analysis of randomized clinical trials requiring prolonged observation of each patient
22. Factors that modify the radio-response of cancer of the nasopharynx
23. Radiation therapy for nasopharyngeal carcinoma: Retrospective review of 105 patients based on a survey of Kansai Cancer Therapist Group
24. Carcinoma of the nasopharyngeal treated by radiotherapy alone: Determinants of local and regional control
25. Carcinoma of the nasopharynx: A review of 86 cases
26. Carcinoma of the nasopharynx: Factors affecting prognosis
27. Radiotherapy for nasopharyngeal carcinoma: Shielding the pituitary may improve therapeutic ratio
28. Hyperfractionated radiation therapy and Bis-chlorethyl nitrosourea in the treatment of malignant glioma - Possible advantage observed at 72.0 Gy in 1.2 Gy b.i.d. fractions: Report of the Radiation Therapy Oncology Group Protocol 8302
29. Nasopharynx
30. Nasopharynx
31. Brief summary of radiobiological principles in fractionated radiotherapy
32. The pathology of late effects of irradiation
33. Radiation pneumonitis: A new approach to the derivation of time-dose factor
34. Damage to mouse lung with neutrons and X-rays
35. Effects of fractionated irradiation on mouse lung and a phenomenon of slow repair
36. Time dependent repair of radiation damage in the rat spinal cord after X-rays and neutrons
37. Turnover of proliferative cells in the spinal cord after X-irradiation and its relation to time-dependent repair of radiation damage
38. Tolerance of the pig kidney to fractionated X-irradiation
39. The response of the pig lung to fractionated doses of X rays
40. Radiation tolerance of the rat spinal cord: Time-dose relationships
41. The influence of the number of fractions and of overall treatment time on local control and late complication rate in squamous cell carcinoma of the larynx
42. Cerebral radionecrosis: Incidence and risk in relation to dose, time, fractionation and volume
43. Comparison of conventional and split-course radiotherapy as primary treatment in carcinoma of the larynx
44. Dose, time, and fraction size issues for late effects in head and neck cancer
45. Dose fractionation and regeneration in radiotherapy of the oral cavity and oropharynx. Part 2. Normal tissue responses: Acute and late effects
46. Late normal tissue sequelae from radiation therapy for carcinoma of the tonsil: Patterns of fractionation study of radiobiology
47. Further analysis of radiobiological parameters from the first and second British Institute of Radiology randomized studies of larynx/pharynx radiotherapy
48. Radiotherapy with thrice-a-day fractionation in a short overall time: Clinical experiences
49. Experience with CHART
50. Myelopathy following hyperfractionated accelerated radiotherapy for anaplastic thyroid carcinoma
51. A randomized trial of accelerated versus conventional radiotherapy in head and neck cancers
52. Impact of spinal cord repair kinetics on the practice of altered fractionation schedules
53. Kinetics of repair in the spinal cord of the rat
54. Time-dose factors in radiotherapy: A review of human data
55. Repair capacity and kinetics for human mucosa and epithelial tumors in the head and neck: Clinical data on the effect of changing the time interval between multiple fractions per day in radiotherapy
56. Repair halftimes estimated from observations of treatment-related morbidity after CHART or conventional radiotherapy in head and neck cancer
57. A new incomplete-repair model based on a 'reciprocal time' pattern of sublethal damage repair
58. The NG2 chondroitin sulphate proteoglycan: A multifactorial proteoglycan associated with immature cells
59. Repair of radiation damage to capillary endothelium
60. Retrospective analysis on treating nasopharyngeal carcinoma with accelerated fractionation (6 fractions per week) in comparison with conventional fractionation (5 fractions per week): Report on 3-year tumor control and normal tissue toxicity